Polaryx Therapeutics, Inc PLYX
$2.07 $0.07 (3.27%) 1D
Last Updated: Aug 21, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
PLYX Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Polaryx Therapeutics, Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Polaryx Therapeutics, Inc. Stock Analysis PLYX
United States Health Care Micro Cap Polaryx Therapeutics, Inc. engages in the manufacturing of biotechnology products. The company is headquartered in Paramus, New Jersey and currently employs 9 full-time employees. The company went IPO on 2026-02-02. Its drug candidate pipeline includes PLX-200 (gemfibrozil), PLX-300 (cinnamic acid), PLX-100, and PLX-400. PLX-200 (gemfibrozil), its advanced drug candidate, is an oral small molecule for the treatment of LSDs. PLX-200 is a repurposed drug that the Company is pursuing through a 505(b)(2) regulatory pathway and is designed to be administered through a novel and proprietary oral solution. PLX-300 (cinnamic acid) is a novel, oral small molecule therapy in IND-enabling studies for the treatment of LSDs. PLX-300 is an unsaturated carboxylic acid that occurs naturally in several plants as a deaminated product of phenylalanine. PLX-100 is a preclinical stage orally administrable combination therapy comprised of its PPARa agonist, PLX-200, and vitamin A, a RXRa agonist.
Polaryx Therapeutics, Inc (PLYX) Chart
Financial Metrics & Statements of Polaryx Therapeutics, Inc (PLYX)
FAQ's for Polaryx Therapeutics, Inc (PLYX)
- As of August 2026, Polaryx Therapeutics, Inc PLYX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Polaryx Therapeutics, Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Polaryx Therapeutics, Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Polaryx Therapeutics, Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Polaryx Therapeutics, Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Polaryx Therapeutics, Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Polaryx Therapeutics, Inc (PLYX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
